{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:50:04Z","timestamp":1788274204907,"version":"build-2803163510"},"reference-count":29,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,5,1]]},"DOI":"10.1210\/jc.2016-4048","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T11:10:32Z","timestamp":1492600232000},"page":"1440-1446","source":"Crossref","is-referenced-by-count":97,"title":["CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations"],"prefix":"10.1210","volume":"102","author":[{"given":"Colin Patrick","family":"Hawkes","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104"},{"name":"National Children\u2019s Research Centre, Crumlin, Dublin, D12 V004, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Applied Genomics, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakon","family":"Hakonarson","sequence":"additional","affiliation":[{"name":"Center for Applied Genomics, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Meyers","sequence":"additional","affiliation":[{"name":"Division of Nephrology, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104"},{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Thummel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, University of Washington School of Pharmacy, Seattle, Washington 98155"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Levine","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, The Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104"},{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,3,3]]},"reference":[{"issue":"2","key":"2019041121070964400_B1","doi-asserted-by":"crossref","first-page":"E268","DOI":"10.1210\/jc.2011-1972","article-title":"Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia","volume":"97","author":"Dauber","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121070964400_B2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJMoa1103864","article-title":"Mutations in CYP24A1 and idiopathic infantile hypercalcemia","volume":"365","author":"Schlingmann","year":"2011","journal-title":"N Engl J Med"},{"issue":"6779","key":"2019041121070964400_B3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(53)90187-1","article-title":"Idiopathic hypercalcaemia in infants","volume":"265","author":"Lightwood","year":"1953","journal-title":"Lancet"},{"issue":"6829","key":"2019041121070964400_B4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0140-6736(54)90094-X","article-title":"Idiopathic hypercalcaemia in infants with failure to thrive","volume":"267","author":"Creery","year":"1954","journal-title":"Lancet"},{"issue":"4","key":"2019041121070964400_B5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2215\/CJN.05360512","article-title":"1,25-(OH)2D-24 hydroxylase (CYP24A1) deficiency as a cause of nephrolithiasis","volume":"8","author":"Nesterova","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2019041121070964400_B6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpeds.2010.02.025","article-title":"Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D-dependent mechanism and response to ketoconazole treatment","volume":"157","author":"Nguyen","year":"2010","journal-title":"J Pediatr"},{"issue":"4","key":"2019041121070964400_B7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/ckj\/sfv028","article-title":"Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole","volume":"8","author":"Sayers","year":"2015","journal-title":"Clin Kidney J"},{"issue":"4","key":"2019041121070964400_B8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1124\/mol.111.076356","article-title":"An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway","volume":"81","author":"Wang","year":"2012","journal-title":"Mol Pharmacol"},{"key":"2019041121070964400_B9","author":"Roizen","year":"2016"},{"issue":"8","key":"2019041121070964400_B10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An official ATS statement: hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"2019041121070964400_B11","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1210\/jcem-59-6-1204","article-title":"Rifampicin-induced adrenal crisis in addisonian patients receiving corticosteroid replacement therapy","volume":"59","author":"Kyriazopoulou","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121070964400_B12","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1210\/jc.2016-1211","article-title":"Association of mutations in SLC12A1 encoding the NKCC2 cotransporter with neonatal primary hyperparathyroidism","volume":"101","author":"Li","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121070964400_B13","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jbmr.1839","article-title":"Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia","volume":"28","author":"Wang","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"33","key":"2019041121070964400_B14","doi-asserted-by":"crossref","first-page":"28729","DOI":"10.1074\/jbc.M111.236679","article-title":"Bioengineering anabolic vitamin D-25-hydroxylase activity into the human vitamin D catabolic enzyme, cytochrome P450 CYP24A1, by a V391L mutation","volume":"286","author":"Kaufmann","year":"2011","journal-title":"J Biol Chem"},{"issue":"1","key":"2019041121070964400_B15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ab.2011.06.043","article-title":"Simultaneous measurement of plasma vitamin D(3) metabolites, including 4\u03b2,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry","volume":"418","author":"Wang","year":"2011","journal-title":"Anal Biochem"},{"issue":"1","key":"2019041121070964400_B16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/mp500429u","article-title":"Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia","volume":"69","author":"Xu","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"5","key":"2019041121070964400_B17","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI116064","article-title":"Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes","volume":"90","author":"Kolars","year":"1992","journal-title":"J Clin Invest"},{"issue":"5","key":"2019041121070964400_B18","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1164\/ajrccm.155.5.9154885","article-title":"Rifampin preventive therapy for tuberculosis infection: experience with 157 adolescents","volume":"155","author":"Villarino","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"2019041121070964400_B19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1164\/rccm.201407-1264OC","article-title":"A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis","volume":"191","author":"Boeree","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2019041121070964400_B20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-0711-7-3","article-title":"Osteomalacia in an HIV-infected man receiving rifabutin, a cytochrome P450 enzyme inducer: a case report","volume":"7","author":"Bolland","year":"2008","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"10","key":"2019041121070964400_B21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1592\/phco.27.10.1361","article-title":"The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers","volume":"27","author":"Pentikis","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"6","key":"2019041121070964400_B22","first-page":"1446","article-title":"Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria","volume":"75","author":"Breslau","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041121070964400_B23","doi-asserted-by":"crossref","first-page":"E423","DOI":"10.1210\/jc.2011-1935","article-title":"Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy","volume":"97","author":"Tebben","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121070964400_B24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing\u2019s disease: is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041121070964400_B25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1086\/431595","article-title":"Hepatotoxicity associated with antifungal therapy after bone marrow transplantation","volume":"41","author":"Wingard","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2019041121070964400_B26","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1248\/bpb.28.1805","article-title":"Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes","volume":"28","author":"Niwa","year":"2005","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"2019041121070964400_B27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/15376520590918847","article-title":"Impact of genetic polymorphism in relation to other factors on expression and function of human drug-metabolizing p450s","volume":"15","author":"Zanger","year":"2005","journal-title":"Toxicol Mech Methods"},{"issue":"3","key":"2019041121070964400_B28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000446663","article-title":"Mutational spectrum of CYP24A1 gene in a cohort of italian patients with idiopathic infantile hypercalcemia","volume":"133","author":"Gigante","year":"2016","journal-title":"Nephron"},{"issue":"4","key":"2019041121070964400_B29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/138920008784220664","article-title":"Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4","volume":"9","author":"Zhou","year":"2008","journal-title":"Curr Drug Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/5\/1440\/16630154\/jc.2016-4048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T04:21:51Z","timestamp":1555042911000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/102\/5\/1440\/3061632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,3]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,3]]},"published-print":{"date-parts":[[2017,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2016-4048","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,5,1]]},"published":{"date-parts":[[2017,3,3]]}}}